| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.69B | +23.2% |
| Cost of Revenue | $276.3M | +29.9% |
| R&D Expense | $199.0M | +34.1% |
| SG&A Expense | $966.1M | +23.3% |
| Operating Income | $451.3M | +19.2% |
| Interest Expense | $1.9M | -24.0% |
| Pre-tax Income | $472.4M | +21.3% |
| Income Tax | $131.6M | +21.6% |
| Net Income | $340.8M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $294.0M | -26.6% |
| Accounts Receivable | $16.4M | -28.0% |
| Inventory | $1.4M | -13.9% |
| Current Assets | $2.81B | +1.8% |
| Total Assets | $4.20B | +7.6% |
| Current Liabilities | $2.53B | +6.6% |
| Long-term Debt | $29.0M | +0.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $485.0M | +32.8% |
| Capital Expenditures | $192.6M | +45.2% |
| Investing Cash Flow | -$196.7M | -744.8% |
| Financing Cash Flow | -$274.7M | -207.9% |
| Free Cash Flow | $292.4M | +25.8% |
| +21.1% |
| EPS (Basic) | $5.91 | +21.6% |
| EPS (Diluted) | $5.88 | +21.5% |
| Total Liabilities |
| $2.89B |
| +6.4% |
| Stockholders' Equity | $1.30B | +10.2% |